Free Trial

Trinity Biotech (TRIB) SEC Filings & 10K Form

Trinity Biotech logo
$0.58 -0.06 (-8.74%)
As of 11:10 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Trinity Biotech SEC Filings

DateFilerForm TypeView
03/25/2025
5:29 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Trinity Biotech (Subject)
Form SCHEDULE 13D/A
03/21/2025
4:00 PM
Trinity Biotech (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
03/14/2025
3:30 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2025
6:30 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2025
7:30 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2025
8:00 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2025
7:36 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/29/2025
4:15 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
10:33 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2024
3:14 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2024
3:05 PM
Trinity Biotech (Filer)
Form 424B5
12/26/2024
5:19 PM
New Main Equity Co., Ltd. (Filed by)
Trinity Biotech (Subject)
Form SCHEDULE 13D
12/26/2024
6:12 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
8:55 PM
MiCo IVD Holdings, LLC (Filed by)
Trinity Biotech (Subject)
Form SCHEDULE 13D/A
12/18/2024
11:02 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
3:42 PM
Trinity Biotech (Filer)
Form 424B5
12/05/2024
3:30 PM
Trinity Biotech (Filer)
Form 424B3
12/02/2024
11:15 PM
Trinity Biotech (Filer)
Form EFFECT
11/29/2024
3:45 PM
Trinity Biotech (Filer)
Form F-3/A
11/15/2024
4:00 PM
Trinity Biotech (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
11/15/2024
12:22 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
4:26 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Trinity Biotech (Subject)
Form SC 13D/A
11/07/2024
11:33 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
12:23 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
12:24 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/07/2024
9:35 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2024
10:22 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
2:07 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
5:01 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
7:11 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
4:14 PM
Trinity Biotech (Filer)
Form 424B5
09/10/2024
9:35 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
12:26 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
9:52 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
10:59 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/29/2024
5:01 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
11:33 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/21/2024
3:40 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2024
12:52 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
4:26 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
4:27 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

07/12/2024
4:03 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2024
3:53 PM
Trinity Biotech (Filer)
Form 424B5
07/11/2024
5:55 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2024
11:15 PM
Trinity Biotech (Filer)
Form EFFECT
06/28/2024
1:34 PM
Trinity Biotech (Filer)
Form F-3/A
06/21/2024
3:15 PM
Trinity Biotech (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
05/28/2024
6:55 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
12:15 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
11:15 PM
Trinity Biotech (Filer)
Form EFFECT
05/07/2024
3:25 PM
Trinity Biotech (Filer)
Form 424B3
04/30/2024
4:14 PM
Trinity Biotech (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
04/30/2024
2:48 PM
Trinity Biotech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/30/2024
11:28 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/05/2024
12:05 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:TRIB) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners